Cargando…

Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy

The increase in diabetic retinopathy (DR) prevalence demonstrates the need for the determination of biomarkers for assessing disease development to obtain an early diagnosis and stop its progression. We aimed to analyse total retinal (RT) and inner retinal layer (IRL) thicknesses in type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Boned-Murillo, Ana, Fernández-Espinosa, Guisela, Orduna-Hospital, Elvira, Díaz-Barreda, Maria Dolores, Sánchez-Cano, Ana, Sopeña-Pinilla, María, Bielsa-Alonso, Sofía, Pinilla, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669203/
https://www.ncbi.nlm.nih.gov/pubmed/38001971
http://dx.doi.org/10.3390/biomedicines11112972
_version_ 1785139640430231552
author Boned-Murillo, Ana
Fernández-Espinosa, Guisela
Orduna-Hospital, Elvira
Díaz-Barreda, Maria Dolores
Sánchez-Cano, Ana
Sopeña-Pinilla, María
Bielsa-Alonso, Sofía
Pinilla, Isabel
author_facet Boned-Murillo, Ana
Fernández-Espinosa, Guisela
Orduna-Hospital, Elvira
Díaz-Barreda, Maria Dolores
Sánchez-Cano, Ana
Sopeña-Pinilla, María
Bielsa-Alonso, Sofía
Pinilla, Isabel
author_sort Boned-Murillo, Ana
collection PubMed
description The increase in diabetic retinopathy (DR) prevalence demonstrates the need for the determination of biomarkers for assessing disease development to obtain an early diagnosis and stop its progression. We aimed to analyse total retinal (RT) and inner retinal layer (IRL) thicknesses in type 2 diabetes mellitus (DM2) patients and correlate these results with retinal sensitivity using swept-source OCT (SS-OCT) and microperimetry. For this purpose, a total of 54 DM2 subjects with moderate diabetic retinopathy (DR) with no signs of diabetic macular oedema (DME) and 73 age-matched healthy individuals were assessed using SS-OCT to quantify retinal thickness in the nine macular areas of the ETDRS grid. Retinal sensitivity was measured via microperimetry with a Macular Integrity Assessment Device (MAIA). The mean ages were 64.06 ± 11.98 years for the DM2 group and 60.79 ± 8.62 years for the control group. DM2 patients presented lower visual acuity (p < 0.001) and a thicker RT (260.70 ± 19.22 μm in the control group vs. 271.90 ± 37.61 μm in the DM2 group, p = 0.01). The retinal nerve fibre layer (RNFL) was significantly lower in the outer nasal area (50.38 ± 8.20 μm vs. 45.17 ± 11.25 μm, p = 0.005) in ganglion cells and inner plexiform layers (GCL+) in DM2. A positive correlation between the LDL-C and RNFL and a negative correlation between HDL-C levels and the inner temporal and central RNFL thickness were detected. The central (p = 0.021) and inner nasal (p = 0.01) areas were negatively correlated between the RNFL and MAIA, while GCL++ was positively correlated with the outer inferior (p = 0.015) and outer nasal areas (p = 0.024). Retinal sensitivity and macular RNFL thickness decrease in DM2 patients with moderate DR with no DME, and this study enables an accurate approach to this disease with personalised assessment based on the DR course or stage. Thus, GCL+ and GCL++ thinning may support ganglion cell loss before the RNFL is affected.
format Online
Article
Text
id pubmed-10669203
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106692032023-11-04 Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy Boned-Murillo, Ana Fernández-Espinosa, Guisela Orduna-Hospital, Elvira Díaz-Barreda, Maria Dolores Sánchez-Cano, Ana Sopeña-Pinilla, María Bielsa-Alonso, Sofía Pinilla, Isabel Biomedicines Article The increase in diabetic retinopathy (DR) prevalence demonstrates the need for the determination of biomarkers for assessing disease development to obtain an early diagnosis and stop its progression. We aimed to analyse total retinal (RT) and inner retinal layer (IRL) thicknesses in type 2 diabetes mellitus (DM2) patients and correlate these results with retinal sensitivity using swept-source OCT (SS-OCT) and microperimetry. For this purpose, a total of 54 DM2 subjects with moderate diabetic retinopathy (DR) with no signs of diabetic macular oedema (DME) and 73 age-matched healthy individuals were assessed using SS-OCT to quantify retinal thickness in the nine macular areas of the ETDRS grid. Retinal sensitivity was measured via microperimetry with a Macular Integrity Assessment Device (MAIA). The mean ages were 64.06 ± 11.98 years for the DM2 group and 60.79 ± 8.62 years for the control group. DM2 patients presented lower visual acuity (p < 0.001) and a thicker RT (260.70 ± 19.22 μm in the control group vs. 271.90 ± 37.61 μm in the DM2 group, p = 0.01). The retinal nerve fibre layer (RNFL) was significantly lower in the outer nasal area (50.38 ± 8.20 μm vs. 45.17 ± 11.25 μm, p = 0.005) in ganglion cells and inner plexiform layers (GCL+) in DM2. A positive correlation between the LDL-C and RNFL and a negative correlation between HDL-C levels and the inner temporal and central RNFL thickness were detected. The central (p = 0.021) and inner nasal (p = 0.01) areas were negatively correlated between the RNFL and MAIA, while GCL++ was positively correlated with the outer inferior (p = 0.015) and outer nasal areas (p = 0.024). Retinal sensitivity and macular RNFL thickness decrease in DM2 patients with moderate DR with no DME, and this study enables an accurate approach to this disease with personalised assessment based on the DR course or stage. Thus, GCL+ and GCL++ thinning may support ganglion cell loss before the RNFL is affected. MDPI 2023-11-04 /pmc/articles/PMC10669203/ /pubmed/38001971 http://dx.doi.org/10.3390/biomedicines11112972 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Boned-Murillo, Ana
Fernández-Espinosa, Guisela
Orduna-Hospital, Elvira
Díaz-Barreda, Maria Dolores
Sánchez-Cano, Ana
Sopeña-Pinilla, María
Bielsa-Alonso, Sofía
Pinilla, Isabel
Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy
title Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy
title_full Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy
title_fullStr Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy
title_full_unstemmed Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy
title_short Changes in Inner Retina Thickness and Macular Sensitivity in Patients with Type 2 Diabetes with Moderate Diabetic Retinopathy
title_sort changes in inner retina thickness and macular sensitivity in patients with type 2 diabetes with moderate diabetic retinopathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669203/
https://www.ncbi.nlm.nih.gov/pubmed/38001971
http://dx.doi.org/10.3390/biomedicines11112972
work_keys_str_mv AT bonedmurilloana changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy
AT fernandezespinosaguisela changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy
AT ordunahospitalelvira changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy
AT diazbarredamariadolores changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy
AT sanchezcanoana changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy
AT sopenapinillamaria changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy
AT bielsaalonsosofia changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy
AT pinillaisabel changesininnerretinathicknessandmacularsensitivityinpatientswithtype2diabeteswithmoderatediabeticretinopathy